Cytoskeleton regulates expression of genes for transforming growth factor-beta 1 and extracellular matrix proteins in dermal fibroblasts

被引:0
|
作者
Varedi, M
Ghahary, A
Scott, PG
Tredget, EE
机构
[1] UNIV ALBERTA, DEPT SURG, EDMONTON, AB, CANADA
[2] UNIV ALBERTA, DEPT BIOCHEM, EDMONTON, AB, CANADA
[3] UNIV ALBERTA, DIV CRIT CARE, EDMONTON, AB, CANADA
关键词
D O I
10.1002/(SICI)1097-4652(199708)172:2<192::AID-JCP6>3.0.CO;2-J
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cytoskeleton not only controls cell morphology but also regulates cell growth, migration, differentiation, and gene expression, events which are fundamental to embryogenesis, carcinogenesis, and wound healing. We have recently reported that reorganization of cytoskeleton induces expression of mRNA for transforming growth factor-beta1 (TGF-beta 1) collagenase, and tissue inhibitor of metalloproteinase-l (TIMP-I) in dermal fibroblasts. In this report we have examined the role of gene transcription in this induction. As judged by nuclear run-on assay, trypsin, EGTA (ethylene glycol-bis (beta-aminoethyl ether) N, N, N', N', tetra-acetic acid), or cytochalasin C (Chs) increased the tate of transcription of the TGF-beta 1 gene by 2.0, 2.7, and 1.6 fold, respectively, and of the collagenase gene by 5.3, 6.2, and 3.3 fold. The rate or transcription of the TIMP-I gene was increased by trypsin (4.3 fold) or EGTA (3.8 fold) but unaffected by Chs. Cytochalasin induced an increase in the rate oi transcription of procollagen I (alpha 1), procollagen I (alpha 2), and fibronectin genes by 1.4, 1.5, and 1.9 fold respectively, while trypsinization or EGTA treatment had no or little Effects an these genes. Since transcription of the TGF-beta 1 gene is believed to be largely governed by the activating protein 1 (API) complex, we also examined the expression of mRNA for c-fos and c-jun protooncoproteins. Trypsinization induced rapid (within 30 min) and transient expression of c-fos mRNA. A 2.4 fold increase in c-jun mRNA was apparent after 4 hr and persisted for at least 24 hr. Actinomycin D (Act D) suppressed the induction of TGF-beta 1 mRNA hy Chs but had less effect on the TGF-beta 1 mRNA in trypsinized cells which had been replated for 4 hr, suggesting that the hall life ai TGF-beta 1 mRNA is reduced in cells with a disassembled cytoskeleton. Simultaneous treatment. with Chs and cycloheximide (Cxm) resulted in a superinduction of TGF-beta 1 mRNA by 88 +/- 23% (n = 4, P < 0.05), which was abrogated by preexposure to Act D. In contrast, the induction of collagenase mRNA by Chs was totally blocked by Cxm, indicating that the Cxm-mediated superinduction is selective and that protein synthesis is required for induction of this mRNA. Our results suggest that the activities of genes Tor proteins involved in the structure (Type I collagen and fibronectin), turnover (collagenase and TIMP-I) and regulation (TGF-beta 1 oi extracellular matrix (ECM), are all governed at least in part by the status of the cytoskeleton. Since the cytoskeleton is reorganized during cell division, migration, and differentiation, these results may have implications for the regulation of ECM during such processes as embryogenesis, carcinogenesis, and wound healing. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:192 / 199
页数:8
相关论文
共 50 条
  • [41] DIFFERENTIAL MODULATION OF COLLAGEN PRODUCTION BY HUMAN DERMAL FIBROBLASTS BY RETINOIC ACID, TRANSFORMING GROWTH FACTOR-BETA AND EPIDERMAL GROWTH-FACTOR
    RAXWORTHY, MJ
    CUNLIFFE, WJ
    WOOD, EJ
    CLINICAL RESEARCH, 1989, 37 (02): : A713 - A713
  • [42] Expression of transforming growth factor-beta 1 (TGF-beta 1) in odontogenic cysts
    Piattelli, A
    Rubini, C
    Fioroni, M
    Favero, L
    Strocchi, R
    INTERNATIONAL ENDODONTIC JOURNAL, 2004, 37 (01) : 7 - 11
  • [43] TRANSFORMING GROWTH FACTOR-BETA1 REGULATES FIBRIN GEL CONTRACTION AND GEL LYSIS BY HUMAN DERMAL FIBROBLASTS
    TUAN, TL
    SUN, D
    NIMNI, ME
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A127 - A127
  • [44] DIFFERENTIAL MODULATION OF COLLAGEN PRODUCTION BY HUMAN DERMAL FIBROBLASTS BY RETINOIC ACID, TRANSFORMING GROWTH FACTOR-BETA AND EPIDERMAL GROWTH-FACTOR
    RAXWORTHY, MJ
    CUNLIFFE, WJ
    WOOD, EJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 504 - 504
  • [45] Novel matrix binding proteins (LTBP:s) for transforming growth factor-beta:s.
    Saharinen, J
    Karonen, T
    Taipale, J
    KeskiOja, J
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 410 - 410
  • [46] Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy
    Goulart, IMB
    Figueiredo, F
    Coimbra, T
    Foss, NT
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (03): : 911 - 917
  • [47] HETEROGENEITY OF LATENT TRANSFORMING GROWTH FACTOR-BETA ISOLATED FROM BONE-MATRIX PROTEINS
    JENNINGS, JC
    MOHAN, S
    ENDOCRINOLOGY, 1990, 126 (02) : 1014 - 1021
  • [48] The beta(4) integrin subunit is expressed in mouse fibroblasts and modulated by transforming growth factor-beta(1)
    Scardigli, R
    Soddu, S
    Falcioni, R
    Crescenzi, M
    Cimino, L
    Sacchi, A
    EXPERIMENTAL CELL RESEARCH, 1996, 227 (02) : 223 - 229
  • [49] Suppression of transforming growth factor-beta 1 expression in keloids after cryosurgery
    Awad, Sara M.
    Ismail, Sahar A.
    Sayed, Doaa S.
    Refaiy, Abeer E.
    Makboul, Rania
    CRYOBIOLOGY, 2017, 75 : 151 - 153
  • [50] Transforming growth factor-beta and platelet derived growth factor regulation of fibrillar fibronectin matrix formation by synovial fibroblasts.
    Sarkissian, M
    Lafyatis, R
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1306 - 1306